Document is current

Article History

Received: 26 February 2025

Revised: 24 March 2025

Accepted: 20 April 2025

First Online: 29 May 2025

Declarations

:

: Conflic of interest The device(s)/drug(s) is/are FDA-approved or approved by corresponding national agency for this indication. No funds were received in support of this work. Relevant financial activities outside the submitted work: A.M. Post: no conflict of interest/ relevant financial activities M. Gaume: no conflict of interest/ relevant financial activities B.J. van Royen: no conflict of interest/ relevant financial activities E.R.C. Janssen: no conflict of interest/ relevant financial activities K.M. Lundine: Institutional research support funding from Euros Spine and Globus Spine M.B. Johnson: Institutional research support funding from Euros Spine and Globus Spine P. Neagoe: no conflict of interest/ relevant financial activities M.C. Kruyt: Euros research grant of 25.000 euro in 2020 L. Boissiere: Consultant and research support from Clarian Spinevision and travel accommodation from Euros JP. Kaleeta Maalu: no conflict of interest/ relevant financial activities J.J.M. Renkens: no conflict of interest/ relevant financial activities M.C. Deml: no conflict of interest/ relevant financial activities A. Stadhouder; yearly institutional research support funding from Euros F. Solla: Funding for congresses and meetings from Medtronic and SMAIO S. Schaible: no conflict of interest/ relevant financial activities C.S. Tabeling: no conflict of interest/ relevant financial activities J. Mielenbrink: no conflict of interest/ relevant financial activities L. Miladi: intellectual property rights with Euros company.